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ABSTRACT: Synaptotagmin and complexin regulate SNARE-
mediated synaptic vesicle exocytosis. It has been proposed
that complexin clamps membrane fusion and that Ca2+-
synaptotagmin displaces complexin from SNARE com-
plexes to relieve this clamping activity. Using a recon-
stituted system, we demonstrate that complexin and
synaptotagmin simultaneously bind to neuronal SNARE
complexes and that both apo-synaptotagmin and com-
plexin inhibit SNARE-mediated membrane fusion. More-
over, the clamping ability of apo-synaptotagmin occluded
the clamping activity of complexin until the arrival of a
Ca2+ trigger, at which point synaptotagmin accelerated
fusion while high concentrations of complexin inhibited
fusion. Thus, the inhibitory patterns of synaptotagmin and
complexin are different, suggesting that SNAREs as-
semble into distinct states along the fusion pathway. These
data also suggest that during synaptotagmin-regulated
vesicle-vesicle fusion, complexin does not function as a
fusion clamp that is relieved by Ca2+-synaptotagmin.
Rapid point-to-point communication in the nervous system
is mediated by Ca2+-triggered exocytosis of neurotransmitter-
ﬁlled synaptic vesicles (SVs). The speed of this fusion event
suggests that the membrane fusion machinery is poised and
ready to respond to Ca2+ with submillisecond kinetics (1).
A number of the components of this machine have been
identiﬁed. It is now established that soluble N-ethylmale-
imide-sensitive factor attachment protein receptor (SNARE)
proteins form the core of the SV fusion apparatus. It is
believed that trans interactions between the vesicle SNARE
(v-SNARE) VAMP 2/synaptobrevin 2 and target membrane
SNAREs (t-SNAREs) syntaxin 1A and SNAP-25B serve to
directly catalyze fusion of SVs with the plasma membrane.
However, little is known concerning the mechanisms by
which accessory proteins control the SNARE complex to
regulate fusion.
Considerable attention has been placed on identifying a
molecular “clamp” that prevents SNARE-mediated fusion
under resting conditions (i.e., in the absence of a Ca2+ signal);
Ca2+ would then serve to relieve the clamp, thus allowing
exocytosis to proceed. Recent efforts to identify this clamp
have focused on the interplay between two proteins that
interact with neuronal SNAREs at various stages of SNARE
complex assembly: synaptotagmin I (syt) and members of
the complexin family of proteins. Syt is a Ca2+ binding
protein found on SVs and serves as the Ca2+ sensor for
synaptic vesicle exocytosis (2). Complexins are small, soluble
proteins expressed in numerous cell types though complexins
I and II are predominantly found in neurons where they serve
a regulatory role during Ca2+-triggered neurotransmitter re-
lease (3).
A handful of recent reports concluded that complexins
clamp SNARE-catalyzed membrane fusion (4-8) and that
Ca2+-syt displaces complexin from SNARE complexes to
alleviate the clamp (4-6, 8, 13). These results support a
model of SV exocytosis in which complexins plays a
negative regulatory role under resting conditions (i.e., prior
to the Ca2+ trigger) and also suggest that syt acts simply as
a positive regulator in response to Ca2+. However, it has
also been reported that complexins are not displaced from
SNARE complexes by syt (6, 9) and that complexins are
not clamps, but instead play a positive role in SNARE-
mediated fusion (10-12). Hence, a consensus about the
physiological and biochemical function of complexin has not
been reached. Here, we have used a reconstituted system to
analyze directly the functional and biochemical roles of full-
length complexin I (cpx-I), and a complexin I fragment [cpx-
I(26-83)] that constitutes the proposed inhibitory domain
of cpx-I used in recent studies (5, 8, 13).
We ﬁrst characterized the interaction of complexin with
membrane-embedded SNAREs. We assembled ternary
SNARE complexes, the favored binding partner for com-
plexin (14), on liposomes (Figure S1a,b of the Supporting
Information). Saturation of membrane-embedded t-SNARE
heterodimers with the cytoplasmic domain of synaptobrevin
2 was conﬁrmed using a coﬂotation assay. Next, we saturated
fully assembled ternary SNARE complexes with cpx-I or
cpx-I(26-83) (Figure S1c,d of the Supporting Information).
Both cpx-I and cpx-I(26-83) preferentially bound ternary
SNARE complexes as compared to t-SNARE heterodimers,
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SNAREs was observed (Figure S1d of the Supporting
Information).
Having established saturable binding of cpx-I and cpx-
I(26-83) to assembled SNARE complexes, we carried out
in vitro membrane fusion assays to assess the impact of these
binding interactions on the function of SNARE proteins
(Figure S2a of the Supporting Information). It is important
to note that for all fusion experiments in this study, t-SNARE
and v-SNARE vesicles were combined in a 9:1 ratio to allow
for multiple rounds of fusion (15). Low concentrations of
cpx-I stimulated SNARE-mediated fusion to a small but
reproducible extent, whereas higher concentrations of cpx-I
inhibited fusion in a dose-dependent manner (∼50% inhibi-
tion at 60 µM cpx-I) (Figure S2b,c of the Supporting
Information). Cpx-I(26-83) failed to show any stimulation
of fusion and only weakly inhibited fusion at the highest
concentration that was tested (Figure S2d,e of the Supporting
Information). We note that saturation occurs at different
concentrations of cpx-I for the binding and fusion reactions.
This apparent discrepancy is likely due to adding cpx-I to
preformed cis-SNARE complexes in the binding assay as
compared to trans-SNARE complexes in the fusion assay
(see the Supporting Information for more details).
Next, we addressed whether syt and cpx-I simultaneously
bind SNAREs and whether cpx-I-mediated inhibition can be
overcome by Ca2+-syt (as proposed in refs 4-6 and 8). We
titrated syt onto ternary SNARE complexes that had been
saturated with cpx-I (Figure 1a,b) in the coﬂotation assay.
For these experiments, we used liposomes that lacked
phosphatidylserine (PS). t-SNARE vesicles lacking PS must
be used for this experiment, in contrast to ref 6, because
Ca2+-syt binds with high afﬁnity to PS (16). With the
omission of PS, any coﬂotation of syt with the vesicles must
be solely due to direct interactions between syt and SNARE
proteins. Even when present in a 3-fold molar excess of cpx-
I, syt had no effect on the extent of cpx-I binding either in
the absence or in the presence of Ca2+ (Figure 1b). Similarly,
saturation of ternary SNARE complexes with cpx-I did not
affect the extent of syt binding (Figure 1b). These data
unambiguously demonstrate that syt and complexin simul-
taneously bind SNARE complexes that have been assembled
onto liposomes [similar results were obtained with cpx-
I(26-83) (Figure S3 of the Supporting Information)].
It has been suggested that membranes must contain anionic
phospholipids, such as PS, for Ca2+-syt to displace cpx-I from
membrane-embedded SNARE complexes (4, 13). Therefore,
we repeated the competition experiments described above
using liposomes that harbored PS (Figure 1c). As expected,
Ca2+-syt exhibited even more robust coﬂotation with these
vesicles due to high-afﬁnity binding of Ca2+-syt to PS. Even
under these conditions, syt had no effect on the interaction
of cpx-I with assembled SNARE complexes. If anything,
the presence of Ca2+-syt may have enhanced slightly the
ability of cpx-I to bind SNARE complexes [similar results
were obtained with cpx-I(26-83) (Figure S3 of the Sup-
porting Information)]. Thus, Ca2+-syt and cpx-I [or cpx-
I(26-83) which was used in refs 5, 8, and 13] interact with
SNARE complexes in a noncompetitive manner under the
conditions of our binding assays. These data argue against a
complexin clamping mechanism that is displaced by
Ca2+-syt (4-6, 8, 13).
In the ﬁnal series of experiments, cpx-I was titrated into
an in vitro fusion assay in the presence of a saturating
concentration of syt (30 µM syt; see ref 17). Fusion was
monitored in the absence of Ca2+ (Figure 2a,b), and after
addition of 1 mM Ca2+ to reaction mixtures at 20 min (Figure
2c,d) (similar to a method used in ref 6). Under these
conditions, if cpx-I acts as a clamp as reported in refs 4-6,
8, and 13, it would be expected to inhibit fusion only in the
absence of Ca2+ and not after a Ca2+ trigger since Ca2+-syt
would overcome the cpx-I clamp to drive fusion. As shown
in Figure 2a,b, in the absence of Ca2+, syt alone inhibited
fusion by ∼25%. Addition of cpx-I to reaction mixtures
containing apo-syt (Ca2+ free) resulted in a small but
reproducible amount of stimulation at low cpx-I concentra-
tions analogous to the ﬁndings obtained using SNAREs alone
in the fusion assay (Figure 2a,b and Figure S2b,c of the
Supporting Information). However, in contrast to what was
observed when cpx-I was added to reaction mixtures
containing SNAREs alone, addition of higher concentrations
of cpx-I to reaction mixtures containing apo-syt only
modestly inhibited fusion beyond what was already achieved
by apo-syt alone (Figure 2a,b). Thus, cpx-I does not appear
to play a major role in clamping SNARE-mediated vesicle-
vesicle fusion prior to a Ca2+ signal when syt is also present
(see the Supporting Information for more details). In
duplicate samples, we triggered syt-stimulated fusion by
FIGURE 1: Binding of cpx-I and syt to membrane-embedded ternary
SNARE complexes. (a) Diagram of the ﬂotation assay used to
monitor binding interactions (see also Figure S1 of the Supporting
Information). (b) Cpx-I (10 µM) and increasing concentrations of
syt were added to ternary SNARE complexes individually or
together and then the complexes subjected to ﬂotation. Vesicles
harbored 70% PC and 30% PE. Binding was monitored in the
absence or presence of Ca2+ (1 mM), and proteins were visualized
by being stained with Coomassie blue. (c) Experiments in panel b
were repeated using vesicles harboring PS (55% PC, 30% PE, and
15% PS). All gels are representative from n g 3.
658 Biochemistry, Vol. 48, No. 4, 2009 Rapid Reportsadding Ca2+ at 20 min (Figure 2c). From these traces, it is
evident that Ca2+-syt stimulates fusion but also that high
concentrations of cpx-I inhibit Ca2+-syt-triggered fusion
(Figure 2c,d).
Therefore, while equal concentrations of apo-syt and cpx-I
clamp fusion to similar extents (see 30 µM cpx-I in Figure
S2b,c of the Supporting Information as compared to 0 µM
cpx-1 in Figure 2a,b), when added to reaction mixtures at
the same time, the clamping ability of cpx-I was largely
occluded by the clamping ability of apo-syt. Interestingly,
after addition of Ca2+ to reaction mixtures containing both
syt and cpx-I, the inhibitory ability of cpx-I was unmasked
and cpx-I efﬁciently inhibited Ca2+-syt-driven fusion (Figure
2d, inset). Since syt binds t-SNAREs before, during, and after
formation of the ternary SNARE complex, whereas com-
plexin preferentially binds to ternary SNARE complexes (see
refs 14 and 17 and Figure S1), it appears that apo-syt inhibits
fusion at early stages of trans-SNARE pairing, as suggested
in ref 17, whereas cpx-I inhibits fusion after trans-SNARE
pairing has progressed further toward complete ternary
SNARE complex formation. Thus, our data likely reﬂect the
functional consequences of concurrent binding of syt and
cpx-I to SNAREs in the reconstituted system.
In summary, we have analyzed the putative clamping role
of cpx-I (4-6, 8) and addressed the controversy regarding
whether syt and cpx-I compete for binding to SNARE
complexes (6, 8, 9, 13). We demonstrate that Ca2+-syt and cpx-I
bind to fully assembled membrane-embedded SNARE com-
plexes (formed on liposomes) at the same time, that cpx-
I(26-83) does not substitute for full-length cpx-I in our fusion
experiments, and that both apo-syt and cpx-I can inhibit
SNARE-mediated fusion. Importantly, inhibition by cpx-I was
not overcome by Ca2+-syt. Therefore, in our system, it does
not appear that cpx-I acts as a fusion clamp that is relieved by
Ca2+-syt but rather that apo-syt and cpx-I inhibit SNAREs at
distinct stages of SNARE complex assembly.
We note that key differences in the experimental conditions
used by various groups to study the function of complexins
could potentially explain why some groups have observed
competition between Ca2+-syt and cpx-I for SNARE binding
while others have not. For example, refs 8 and 13 report
that Ca2+-syt can displace cpx-I(26-83) from cis-SNARE
complexes embedded in planar lipid bilayers, whereas our
experiments suggest that Ca2+-syt cannot displace cpx-I from
cis-SNARE complexes formed on liposomes (diameter of
∼50 nm). The differences in these reports suggest that
interactions between regulatory proteins and the SNARE
complex might be profoundly affected by membrane cur-
vature. This is an important consideration since highly curved
membranes form critical intermediates during the fusion
reaction (18).
SUPPORTING INFORMATION AVAILABLE
Detailed methods, Figures S1-S3, and supporting text and
references. This material is available free of charge via the
Internet at http://pubs.acs.org.
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FIGURE 2: In vitro membrane fusion regulated by cpx-I and syt. (a)
Increasing concentrations of cpx-I were added to fusion reaction
mixtures containing 30 µM syt. t+v denotes fusion reaction
mixtures lacking cpx-I and syt. As a control, the cytoplasmic domain
of synaptobrevin 2 (cd-syb, 10 µM) was added to t+v to inhibit
SNARE-mediated fusion. Fusion was monitored for 120 min at 37
°C, normalized to the maximum donor ﬂuorescence signal (% Max.
ﬂuorescence), and plotted as a function of time. Reactions were
carried out in 0.2 mM EGTA. (b) The ﬁnal extent of fusion at each
cpx-I concentration tested in panel a was normalized to the ﬁnal
extent of fusion obtained by t+v( %t +v). (c) Experiments were
conducted as described for panel a except Ca2+ (1 mM) was added
to reaction mixtures at 20 min. (d) Data from panel c were
normalized as in panel b. The inset shows the ﬁnal extent of fusion
at each cpx-I concentration tested in panels a and c normalized to
the extent of fusion obtained in reaction mixtures containing syt,
but lacking cpx-I (% t+v+syt). All fusion traces are representative
from n g 3. Data in panels b and d represent the mean ( the
standard error of the mean from n g 3.
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